Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 15, Issue 8, 1996, Pages 625-634

  Bodey, G ^a   Abi Said, D ^a   Rolston, K ^a   Raad, I ^a   Whimbey, E ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOPERAZONE; IMIPENEM; SULBACTAM; VANCOMYCIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; COLITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEVER; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MAJOR CLINICAL STUDY; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RASH; SEIZURE; SUPERINFECTION; VOMITING;

EID: 0029794513     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01691147     Document Type: Article

References (35)

1. Schimpff SC: Therapy of infection in patients with granulocytopenia. Medical Clinics of North America 1977, 61: 1101-1118.
2. Bodey GP Nies BA, Mohberg NR, Freireich EJ: Use of gamma globulin in infection in acute leukemia patients. Journal of American Medical Association 1964, 190: 1099-1102.
3. Pizzo P: Granulocytopenia and cancer therapy: past problems, current solutions, future challenges. Cancer 1984, 54, Supplement: 2649-2661.
4. Ho WG, Winston DJ: Infection and transfusions therapy in acute leukaemia. Clinical Haematology 1986, 15: 873-904.
5. Pizzo PA, Robicard KJ, Wesley R, Commers J: Fever in the pédiatrie and young adult patient with cancer: a prospective study of 1001 episodes. Medicine 1982, 61: 153-165.
6. Keating MJ, Bodey GR Valdivieso M, Rodriguez V; A randomized comparative trial of three aminoglycosides comparison of continuous infusions of gentamicin, amikacin and sisomicin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies. Medicine 1979, 58: 159-170.
7. Fainstein V, Bodey GR Bolivar R, Elting L, McCredie KB, Keating MJ: Moxalactam plus ticarcillin ortobramycin in the treatment of febrile episodes in granulocytopenic cancer patients. Archives of Internal Medicine 1984, 144: 1766-1770.
8. Anaissie EJ, Fainstein V, Bodey GR Rolston K, Elting L, Kantarjian H, Cabanillas F, McCredie KB: Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients. American Journal of Medicine 1988, 84: 581-589.
9. Fainstein V, Bodey GR Elting L, Bolivar R, Keating MJ, McCredie KB, Valdivieso M: A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients. Journal of Antimicrobial Chemotherapy 1983, 12, Supplement A: 101-110.
10. Pizzo R Hathorn J, Hiemenz J, Browne M, Commers J, Cotton D, Gress J, Longo D, Marshall D, McKnight J, Rubin N, Skelton J, Thaler M, Wesley R: A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. New England Journal of Medicine 1986, 315: 552-558.
11. Mortimer J, Miller S, Black D, Kwok K, Kirby WE: Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients. American Journal of Medicine 1988, 85: 17-20.
12. De Pauw BE, Deresinski SC, Feld R, Lane-Allman EF, Donnelly P, for the Intercontinental Antimicrobial Study Group: Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. Annals of Internal Medicine 1994, 120: 834-844.
13. Winston DJ, Winston GH, Bruckner DA, Champlin RE: Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone. Annals of Internal Medicine 1991, 115: 849-859.
14. Rolston KVI, Berkey P, Bodey GP, Anaissie EJ, Khardori NM, Joshi JH, Keating MJ, Holmes FA, Cabanillas FF, Elting L: A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients. Archives of Internal Medicine 1992,152: 283-291.
15. Liang R, Yung R, Chiu E, Chau PY, Chan TK, Lam WK, Todd D: Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients. Antimicrobial Agents and Chemotherapy 1990, 34: 1336-1341.
16. Freifeld AG, Walsh T, Marshall D, Gress J, Steinberg SM, Hathorn J, Rubin M, Jarosinski P, Gill V, Young RC, Pizzo PA: Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem. Journal of Clinical Oncology 1995, 13: 165-176.
17. English AR, Retsema JA, Girard AE, Lynch JE, Barth WE: CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta lactams: initial bacteriological characterization. Antimicrobial Agents and Chemotherapy 1978, 14: 414-419.
18. Bodey GP, Miller P, Ho DH: In vitro assessment of sulbactam plus cefoperazone in the treatment of bacteria isolated from cancer patients. Diagnostic Microbiology and Infectious Diseases 1989, 12, Supplement: 209-214.
19. Jauregui LE, Appelbaum PC, Fabian TC, Hageage G, Strausbaugh L, Martin LF: A randomized clinical study of cefoperazone and sulbactam versus gentamicin and clindamycin in the treatment of intra-abdominal infections, Journal of Antimicrobial Chemotherapy 1990, 25: 423-433.
20. Horiuchi A, Hasegawa H, Kageyama T, Yonezawa T, Kitani T, Masaoka T, Yasunaga K, Kawagoe H, Nagai I: Efficacy of sulbactam/cefoperazone for the treatment of infections in patients with hematologic diseases. Diagnostic Microbiology and Infectious Diseases 1989, 12, Supplement: 215-219.
21. Chandrasekar PH, Sluchak JA, Kruse JA: Therapy with cefoperazone plus sulbactam against disseminated infection due to cefoperazone-resistant Pseudomonas aeruginosa and Escherichia coli in granulocytopenic mice. Antimicrobial Agents and Chemotherapy 1993, 37: 1927-1930.
22. Bodey GP, Elting LS, Narro J, Koller C, O'Brien S, Estey E, Benjamin R: An open trial of cefoperazone plus sulbactam for the treatment of fever in cancer patients. Journal of Antimicrobial Chemotherapy 1993, 32: 141-152.
23. Norrby S, Rogers J, Ferber LF, Jones KH, Zacchei AG, Weidner LL, Demetriades JL, Gravallese DA, Hsieh JYK: Disposition of radiolabeled imipenem and cilastatin in normal human volunteers. Antimicrobial Agents and Chemotherapy 1984, 26: 707-714.
24. Elting LS, Bodey GP, Keefe BH: Septicemia and shock syndrome due to viridans streptococci: a case controlled study of predisposing factors. Clinical infectious Diseases 1992, 14: 1202-1207.
25. Bodey GP, Elting L, Jones P, Alvarez ME, Rolston K, Fainstein V: Imipenem/cilastatin therapy of infections in cancer patients. Cancer 1987, 60: 255-262.
26. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 1958, 53: 457-481.
27. Koll BS, Brown AE: The changing epidemiology of infections at cancer hospitals. Clinical Infectious Diseases 1993, 17, Supplement 2: 322-327.
28. Johnson AP, Uttley AHC, Woodford N, George RC: Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clinical Microbiology Reviews 1990, 3: 280-291.
29. Bodey GP: Candidiasis in cancer patients. American Journal of Medicine 1984, 77, Supplement 4D: 13-19.
30. Stone HH, Kolb LD, Currie CA, Geheber CE, Cuzzel JZ: Candida sepsis: pathogenesis and principles of treatment. Annals of Surgery 1974, 179: 697-711.
31. Kennedy MJ, Volz PA: Effect of various antibiotics on gastrointestinal colonization and dissemination by Candida albicans. Sabouraudia 1985, 23: 265-273.
32. Michea-Hamzehpour M, Aukenthaler MR, Junz J, Pechere JC: Effect of a single dose of cefotaxime or ceftriaxone on human fecal flora. A double-blind study. Drugs 1988, 35, Supplement 2: 6-11.
33. Seelig MS: Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses. Bacteriological Reviews 1966, 30: 442-459.
34. Samonis G, Anaissie EJ, Bodey GP: Effects of broadspectrum antimicrobial agents on yeast colonization of the gastrointestinal tracts of mice. Antimicrobial Agents and Chemotherapy 1990, 34: 2420-2422.
35. Samonis G, Gikas A, Anaissie EJ, Vrenzos G, Maraki S, Tselentis Y, Bodey GP: Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrobial Agents and Chemotherapy 1993, 37: 51-53.